Oncogenic pathways implicated in ovarian epithelial cancer

被引:66
作者
Nicosia, SV
Bai, WL
Cheng, JQ
Coppola, D
Kruk, PA
机构
[1] Univ S Florida, Coll Med, Dept Pathol & Lab Med, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
关键词
D O I
10.1016/S0889-8588(03)00056-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian epithelial cancer is a complex group of neoplasms with an overall poor prognosis. Comprehension of this cancer pathobiology suffers because of an incomplete understanding of precursor lesions and the absence of an orthotopic animal model. There have been a growing number of studies aimed at identifying controls, mechanisms, and signal transduction. pathways that permit or inhibit cell growth and apoptosis in malignant ovarian epithelial cells. These studies are summarized in this article with emphasis on data obtained within the authors' Ovarian Epithelial Cancer Pathobiology Program, where the roles of the Akt oncogene, telomerase, estrogens, and insulin-like growth factor receptor I in ovarian epithelial cancer are under investigation.
引用
收藏
页码:927 / +
页数:19
相关论文
共 127 条
[51]   The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis [J].
Jiang, K ;
Coppola, D ;
Crespo, NC ;
Nicosia, SV ;
Hamilton, AD ;
Sebti, SM ;
Cheng, JQ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) :139-148
[52]   INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND IGF-BINDING PROTEIN-2 ARE INCREASED IN CYST FLUIDS OF EPITHELIAL OVARIAN-CANCER [J].
KARASIK, A ;
MENCZER, J ;
PARIENTE, C ;
KANETY, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :271-276
[53]   Requirement of estrogen receptor expression and function for [12Val] K-Ras-mediated NIH3T3 cell transformation [J].
Kato, K ;
Sakamoto, T ;
Wake, N .
ONCOLOGY, 1998, 55 :45-52
[54]   ACTIVATION OF THE ESTROGEN-RECEPTOR THROUGH PHOSPHORYLATION BY MITOGEN-ACTIVATED PROTEIN-KINASE [J].
KATO, S ;
ENDOH, H ;
MASUHIRO, Y ;
KITAMOTO, T ;
UCHIYAMA, S ;
SASAKI, H ;
MASUSHIGE, S ;
GOTOH, Y ;
NISHIDA, E ;
KAWASHIMA, H ;
METZGER, D ;
CHAMBON, P .
SCIENCE, 1995, 270 (5241) :1491-1494
[55]   Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells [J].
Kawai, H ;
Li, HC ;
Chun, P ;
Avraham, S ;
Avraham, HK .
ONCOGENE, 2002, 21 (50) :7730-7739
[56]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[57]  
Kiyozuka Y, 2000, ANTICANCER RES, V20, P203
[58]  
KOMMOSS F, 1996, HORMONE DEPENDENT CA, P541
[59]   Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer [J].
Kruk, PA ;
Godwin, AK ;
Hamilton, TC ;
Auersperg, N .
GYNECOLOGIC ONCOLOGY, 1999, 73 (02) :229-236
[60]   Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas [J].
Kurose, K ;
Zhou, XP ;
Araki, T ;
Cannistra, SA ;
Maher, ER ;
Eng, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :2097-2106